Skip to main content Accessibility help
×
Home
Hostname: page-component-59b7f5684b-j5sqr Total loading time: 1.457 Render date: 2022-09-28T17:42:06.244Z Has data issue: true Feature Flags: { "shouldUseShareProductTool": true, "shouldUseHypothesis": true, "isUnsiloEnabled": true, "useRatesEcommerce": false, "displayNetworkTab": true, "displayNetworkMapGraph": false, "useSa": true } hasContentIssue true

Book contents

Chapter 28 - Disorders of Creatine Metabolism: Creatine Deficiency Syndromes and Movement Disorders

from Section II - A Metabolism-Based Approach to Movement Disorders and Inherited Metabolic Disorders

Published online by Cambridge University Press:  24 September 2020

Darius Ebrahimi-Fakhari
Affiliation:
Harvard Medical School
Phillip L. Pearl
Affiliation:
Harvard Medical School
Get access

Summary

Creatine is synthetized from two amino acids, arginine and glycine, in the kidney, liver, and pancreas. Two enzymes that are involved in the synthesis of creatine are L-arginine:glycine amidinotransferase (AGAT) (EC 2.1.4.1), highly expressed in the kidney, and guanidinoacetate N-methyltransferase (GAMT) (EC 2.1.1.2), which is highly expressed in the liver.

Type
Chapter
Information
Movement Disorders and Inherited Metabolic Disorders
Recognition, Understanding, Improving Outcomes
, pp. 342 - 347
Publisher: Cambridge University Press
Print publication year: 2020

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Mercimek-Mahmutoglu, S, Salomons, GS. Creatine deficiency syndromes. GeneReviews®. 2009;Jan 15 (updated Dec 10, 2015).Google Scholar
Desroches, CL, Patel, J, Wang, P, et al. Carrier frequency of guanidinoacetate methyltransferase deficiency in the general population by functional characterization of missense variants in the GAMT gene. Mol Genet Genomics. 2015;290(6):2163–71.CrossRefGoogle ScholarPubMed
DesRoches, CL, Bruun, T, Wang, P, Marshall, CR, Mercimek-Mahmutoglu, S. Arginine–glycine amidinotransferase deficiency and functional characterization of missense variants in GATM. Hum Mutat. 2016;37(9):926–32.CrossRefGoogle ScholarPubMed
DesRoches, CL, Patel, J, Wang, P, et al. Estimated carrier frequency of creatine transporter deficiency in females in the general population using functional characterization of novel missense variants in the SLC6A8 gene. Gene. 2015;565(2):187–91.CrossRefGoogle ScholarPubMed
Stockler, S, Holzbach, U, Hanefeld, F, et al. Creatine deficiency in the brain: A new, treatable inborn error of metabolism. Pediatr Res. 1994;36(3):409–13.CrossRefGoogle ScholarPubMed
Mercimek-Mahmutoglu, S, Stoeckler-Ipsiroglu, S, Adami, A, et al. GAMT deficiency: Features, treatment, and outcome in an inborn error of creatine synthesis. Neurology. 2006;67(3):480–4.CrossRefGoogle Scholar
Stockler-Ipsiroglu, S, van Karnebeek, C, Longo, N, et al. Guanidinoacetate methyltransferase (GAMT) deficiency: Outcomes in 48 individuals and recommendations for diagnosis, treatment and monitoring. Mol Genet Metab. 2014;111(1):1625.CrossRefGoogle ScholarPubMed
Mercimek-Mahmutoglu, S, Ndika, J, Kanhai, W, et al. Thirteen new patients with guanidinoacetate methyltransferase deficiency and functional characterization of nineteen novel missense variants in the GAMT gene. Hum Mutat. 2014;35(4):462–9.CrossRefGoogle ScholarPubMed
Khaikin, Y, Sidky, S, Abdenur, J, et al. Treatment outcome of twenty-two patients with guanidinoacetate methyltransferase deficiency: An international retrospective cohort study. Eur J Paediatr Neurol. 2018;22(3):369–79.CrossRefGoogle Scholar
O’Rourke, DJ, Ryan, S, Salomons, G, et al. Guanidinoacetate methyltransferase (GAMT) deficiency: Late onset of movement disorder and preserved expressive language. Dev Med Child Neurol. 2009;51(5):404–7.CrossRefGoogle ScholarPubMed
Dhar, SU, Scaglia, F, Li, FY, et al. Expanded clinical and molecular spectrum of guanidinoacetate methyltransferase (GAMT) deficiency. Mol Genet Metab. 2009;96(1):3843.CrossRefGoogle ScholarPubMed
Morris, AA, Appleton, RE, Power, B, et al. Guanidinoacetate methyltransferase deficiency masquerading as a mitochondrial encephalopathy. J Inherit Metab Dis. 2007;30(1):100.CrossRefGoogle ScholarPubMed
Item, CB, Stockler-Ipsiroglu, S, Stromberger, C, et al. Arginine:glycineamidinotransferase deficiency: The third inborn error of creatine metabolism in humans. Am J Hum Genet. 2001;69(5):1127–33.CrossRefGoogle Scholar
Stockler-Ipsiroglu, S, Apatean, D, Battini, R, et al. Arginine:glycineamidinotransferase (AGAT) deficiency: Clinical features and long term outcomes in 16 patients diagnosed worldwide. Mol Genet Metab. 2015;116(4):252–9.CrossRefGoogle Scholar
Salomons, GS, van Dooren, SJ, Verhoeven, NM, et al. X-linked creatine-transporter gene (SLC6A8) defect: A new creatine-deficiency syndrome. Am J Hum Genet. 2001;68(6):1497–500.CrossRefGoogle ScholarPubMed
van de Kamp, JM, Betsalel, OT, Mercimek-Mahmutoglu, S, et al. Phenotype and genotype in 101 males with X-linked creatine transporter deficiency. J Med Genet. 2013;50(7):463–72.CrossRefGoogle ScholarPubMed
van de Kamp, JM, Mancini, GM, Salomons, GS. X-linked creatine transporter deficiency: Clinical aspects and pathophysiology. J Inherit Metab Dis. 2014;37(5):715–33.CrossRefGoogle ScholarPubMed
Anselm, IA, Alkuraya, FS, Salomons, GS, et al. X-linked creatine transporter defect: A report on two unrelated boys with a severe clinical phenotype. J Inherit Metab Dis. 2006;29(1):214–9.CrossRefGoogle ScholarPubMed
van Spronsen, FJ, Reijngoud, DJ, Verhoeven, NM, et al. High cerebral guanidinoacetate and variable creatine concentrations in argininosuccinate synthetase and lyase deficiency: Implications for treatment? Mol Genet Metab. 2006;89(3):274–6.CrossRefGoogle ScholarPubMed
Nanto-Salonen, K, Komu, M, Lundbom, N, et al. Reduced brain creatine in gyrate atrophy of the choroid and retina with hyperornithinemia. Neurology. 1999;53(2):303–7.CrossRefGoogle ScholarPubMed
Martinelli, D, Haberle, J, Rubio, V, et al. Understanding pyrroline-5-carboxylate synthetase deficiency: Clinical, molecular, functional, and expression studies, structure-based analysis, and novel therapy with arginine. J Inherit Metab Dis. 2012;35(5):761–76.CrossRefGoogle ScholarPubMed
Schulze, A, Hoffmann, GF, Bachert, P, et al. Presymptomatic treatment of neonatal guanidinoacetate methyltransferase deficiency. Neurology. 2006;67(4):719–21.CrossRefGoogle ScholarPubMed
El-Gharbawy, AH, Goldstein, JL, Millington, DS, et al. Elevation of guanidinoacetate in newborn dried blood spots and impact of early treatment in GAMT deficiency. Mol Genet Metab. 2013;109(2):215–7.CrossRefGoogle ScholarPubMed
Viau, KS, Ernst, SL, Pasquali, M, et al. Evidence-based treatment of guanidinoacetate methyltransferase (GAMT) deficiency. Mol Genet Metab. 2013;110(3):255–62.CrossRefGoogle ScholarPubMed
Ndika, JD, Johnston, K, Barkovich, JA, et al. Developmental progress and creatine restoration upon long-term creatine supplementation of a patient with arginine: glycineamidinotransferase deficiency. Mol Genet Metab. 2012;106(1):4854.CrossRefGoogle ScholarPubMed
Battini, R, Alessandri, MG, Leuzzi, V, et al. Arginine:glycineamidinotransferase (AGAT) deficiency in a newborn: Early treatment can prevent phenotypic expression of the disease. J Pediatr. 2006;148(6):828–30.CrossRefGoogle Scholar
Valayannopoulos, V, Boddaert, N, Chabli, A, et al. Treatment by oral creatine, L-arginine and L-glycine in six severely affected patients with creatine transporter defect. J Inherit Metab Dis. 2012;35(1):151–7.CrossRefGoogle ScholarPubMed
van de Kamp, JM, Pouwels, PJ, Aarsen, FK, et al. Long-term follow-up and treatment in nine boys with X-linked creatine transporter defect. J Inherit Metab Dis. 2012;35(1):141–9.CrossRefGoogle ScholarPubMed
Chilosi, A, Leuzzi, V, Battini, R, et al. Treatment with L-arginine improves neuropsychological disorders in a child with creatine transporter defect. Neurocase. 2008;14(2):151–61.CrossRefGoogle Scholar
Fons, C, Sempere, A, Arias, A, et al. Arginine supplementation in four patients with X-linked creatine transporter defect. J Inherit Metab Dis. 2008;31(6):724–8.CrossRefGoogle ScholarPubMed
Bruun, TUJ, Sidky, S, Bandeira, AO, et al. Treatment outcome of creatine transporter deficiency: International retrospective cohort study. Metab Brain Dis. 2018;33(3):875–84.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×